Sandra Levy
ARTICLES BY THIS AUTHOR
- 3/14/2024
Fresenius Kabi obtains FDA OK for biosimilar Tyenne
Biosimlar Tyenne is used in the treatment of several autoimmune diseases, including rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis and systemic juvenile idiopathic arthritis. - 3/14/2024
Cencora’s CEO Steve Collis to retire, Robert Mauch to take reins as president/CEO
Cencora’s CEO Steven Collis will transition to executive chair; COO Robert Mauch will become president and CEO. - 3/13/2024
Aurobindo receives FDA nod for generic Myfortic DR Tablets
Mycophenolic Acid DR Tablets are indicated for prophylaxis of organ rejection in certain pediatric and adult kidney transplant patients. - 3/13/2024
Sens. Wyden, Crapo advocate for PBM reform during NACDS RxIMPACT Day
The reforms would finally address the manipulative practices of pharmaceutical middlemen, NACDS said. - 3/13/2024
McKesson opens registration for ideaShare
McKesson's ideaShare event will be held in New Orleans from June 23–26. - 3/13/2024
DoorDash expands food access for SNAP customers with new grocery partners
DoorDash has added over a dozen new grocers with 6,000 locations nationwide for on-demand grocery delivery with SNAP/EBT payments. - 3/13/2024
FDA permits limited claim that yogurt may reduce Type 2 diabetes risk
The FDA will permit dairy companies to say that eating yogurt regularly may reduce the risk of Type 2 diabetes, according to limited scientific evidence. - 3/13/2024
Nutri-Grain, Kroger join No Kid Hungry to help Ohio kids
Nutri-Grain is teaming up with Kroger to donate $50,000 to No Kid Hungry, to help organizations, schools and community groups across the state of Ohio - 3/13/2024
Dollar General reports Q4, fiscal year 2023 results
Dollar General’s fourth quarter net sales decreased 3.4% to $9.9 billion; fiscal year net sales increased 2.2% to $38.7 billion. - 3/12/2024
Sandoz receives FDA approval for Prolia, Xgeva biosimilars
Wyost and Jubbonti are interchangeable with and approved by FDA for all indications of Xgeva and Prolia.
